Specifically, 2,3-dihydroxy-2-methyl-butyrate levels mediated the association between the DCXR gene and BPH, while 3-methyl-2-oxovalerate levels mediated the effect of PUS1 on PCa. The gene discussed is DCXR; the disease is benign prostatic hyperplasia.